Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
7.62
-0.16 (-2.06%)
Jun 11, 2026, 9:50 AM CST
29.81% (1Y)
| Market Cap | 4.30B +51.7% |
| Revenue (ttm) | 1.78B +1.1% |
| Net Income | 61.07M +98.3% |
| EPS | 0.11 +97.9% |
| Shares Out | 552.92M |
| PE Ratio | 70.66 |
| Forward PE | n/a |
| Dividend | 0.01 (0.17%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 5,370,900 |
| Open | 7.66 |
| Previous Close | 7.78 |
| Day's Range | 7.49 - 7.73 |
| 52-Week Range | 5.51 - 9.44 |
| Beta | 0.68 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |